Awm Investment Company, Inc. Invo Bioscience, Inc. Transaction History

Awm Investment Company, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.15 - $4.96 $88,779 - $2.94 Million	-591,860 Reduced 94.87%	32,000 $25,000
Q2 2022 Aug 12, 2022	SELL	$0.64 - $2.66 $342,537 - $1.42 Million	-535,215 Reduced 46.18%	623,860 $411,000
Q2 2021 Aug 13, 2021	BUY	$3.71 - $5.18 $775,204 - $1.08 Million	208,950 Added 21.99%	1,159,075 $5.39 Million
Q1 2021 May 13, 2021	BUY	$2.96 - $9.4 $962,370 - $3.06 Million	325,125 Added 52.02%	950,125 $4.11 Million
Q4 2020 Feb 12, 2021	BUY	$3.0 - $9.47 $1.88 Million - $5.92 Million	625,000 New	625,000 $1.88 Million

14.1K

Ticker INVO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,169,700
Market Cap $10.1M
Description
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Awm Investment Company, Inc. with notifications on news.